Zomedica Corp. (NYSEAMERICAN:ZOM) Director Acquires $12,000.00 in Stock

Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers bought 100,000 shares of Zomedica stock in a transaction dated Monday, November 11th. The stock was acquired at an average cost of $0.12 per share, for a total transaction of $12,000.00. Following the purchase, the director now directly owns 2,425,000 shares in the company, valued at approximately $291,000. The trade was a 4.30 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Zomedica Trading Down 6.7 %

NYSEAMERICAN:ZOM opened at $0.14 on Friday. Zomedica Corp. has a 12-month low of $0.12 and a 12-month high of $0.23.

Hedge Funds Weigh In On Zomedica

A hedge fund recently raised its stake in Zomedica stock. Virtu Financial LLC grew its position in Zomedica Corp. (NYSEAMERICAN:ZOM) by 1,585.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 168,773 shares of the company’s stock after buying an additional 158,757 shares during the period. Virtu Financial LLC’s holdings in Zomedica were worth $25,000 at the end of the most recent quarter. 8.95% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Noble Financial raised shares of Zomedica to a “strong-buy” rating in a research note on Monday.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.